Low-Abundance Serum Proteins as Biomarkers for Cardiovascular Disease
Using deoxyoligonucleotides to bind proteins with high sensitivity and specificity
Many individuals with cardiovascular disease (CVD) do not present with any of the disorder’s classic risk factors. Circulating proteins are a promising source for CVD biomarkers to complement existing clinically-relevant indicators. These proteins are often released at the very onset of CVD, well before visible manifestations or symptoms. However, detecting them at these low concentrations is a challenge.
Download this white paper from SomaLogic to learn how the SomaScan® assay overcomes obstacles linked with other assays, including insufficient detection sensitivity, non-specificity, and cross-reactivity.
